Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 17Pancreatic Neoplasms 6Neoplasm Metastasis 4Colorectal Neoplasms 3Breast Neoplasms 3Biliary Tract Neoplasms 3Recurrence 2Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Liver Diseases 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1Advanced Biliary Tract Cancer 1

Interventions

atezolizumab 2Sorafenib 2Bevacizumab 2titanium silicide 1ledipasvir, sofosbuvir drug combination 1halofantrine 1genexol-PM 1durvalumab 1avatrombopag 1aumolertinib 1Sunitinib 1Ramucirumab 1Neoadjuvant Therapy 1N-monoacetylcystine 1Leucovorin 1Injections 1Immunotherapy 1Formyltetrahydrofolates 1Everolimus 1Cisplatin 1Catheter Ablation 1Adjuvants, Pharmaceutic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Diseases × titanium silicide × Clear all
NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Second Military Medical University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡